Literature DB >> 18304639

Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.

Julia Rolf1, Emma Berntman, Martin Stenström, Emma M K Smith, Robert Månsson, Hanna Stenstad, Tetsuya Yamagata, William Agace, Mikael Sigvardsson, Susanna L Cardell.   

Abstract

CD1d-restricted natural killer T (NKT) cells can have multiple effects on an immune response, including the activation, regulation and attraction of innate immune cells, and modulation of adaptive immunity. Recent studies reveal that there are distinct subsets of NKT cells which selectively perform some of the functions attributed to CD1d-restricted cells, but the mechanisms underlying these functional differences have not been resolved. Our aim in this study was to identify novel NKT cell associated traits that would provide important insight into NKT cell activation and function. To this end, we have performed gene expression profiling of two separate subsets of NKT cells, analyzing genes differentially expressed in these cells compared to conventional CD4(+)NK1.1(-) T cells. We identify different sets of genes over expressed in each of the two NKT cell types, as well as genes that are common to the two CD1d-restricted NKT cell populations analyzed. A large number of these genes are highly relevant for NKT cell development, activation and function. Each NKT subtype displayed a unique set of chemokine receptors, integrins and molecules related to effector function, supporting the notion that distinct NKT cells can be selectively engaged and have diverse functions in different types of immune reactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304639     DOI: 10.1016/j.molimm.2007.12.022

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  23 in total

1.  CD1d-restricted NKT cells modulate placental and uterine leukocyte populations during chlamydial infection in mice.

Authors:  Mohamed Habbeddine; Philippe Verbeke; Christiane Delarbre; René Moutier; Stéphane Prieto; David M Ojcius; Colette Kanellopoulos-Langevin
Journal:  Microbes Infect       Date:  2013-08-31       Impact factor: 2.700

Review 2.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 3.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

4.  Transcriptional regulator Id2 controls survival of hepatic NKT cells.

Authors:  Laurel A Monticelli; Yang Yang; Jamie Knell; Louise M D'Cruz; Michael A Cannarile; Isaac Engel; Mitchell Kronenberg; Ananda W Goldrath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 5.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

Review 6.  Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.

Authors:  Subramanya Hegde; Lisa Fox; Xiaohua Wang; Jenny E Gumperz
Journal:  Immunology       Date:  2010-05-11       Impact factor: 7.397

7.  Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.

Authors:  Shiny Nair; Chandra Sekhar Boddupalli; Rakesh Verma; Jun Liu; Ruhua Yang; Gregory M Pastores; Pramod K Mistry; Madhav V Dhodapkar
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

8.  Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.

Authors:  Fredrik Wermeling; Sara M Lind; Emilie Domange Jordö; Susanna L Cardell; Mikael C I Karlsson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

9.  Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

Authors:  Karina I Carvalho; Karina M Melo; Fernanda R Bruno; Jennifer E Snyder-Cappione; Douglas F Nixon; Beatriz T Costa-Carvalho; Esper G Kallas
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

10.  Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.

Authors:  Maria Blomqvist; Sara Rhost; Susann Teneberg; Linda Löfbom; Thomas Osterbye; Manfred Brigl; Jan-Eric Månsson; Susanna L Cardell
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.